BDNF and depressive symptom measurement: Imbalances in the levels of monoamine neurotransmitters or neurotrophic factors are the main hypotheses for the pathogenesis of depression, based primarily on deficiencies in biogenic amine systems or brain-derived neurotrophic factor (BDNF) signaling, respectively (Ma et al., 2021a; Li et al., 2021).